BlackRock Japan’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-43
Closed -$6K – 1319
2016
Q2
$6K Sell
43
-199
-82% -$26.7K ﹤0.01% 1327
2016
Q1
$35K Hold
242
– – ﹤0.01% 1092
2015
Q4
$52K Hold
242
– – ﹤0.01% 1021
2015
Q3
$39K Buy
+242
New +$52.4K ﹤0.01% 1010
2015
Q1
– Sell
-245
Closed -$47K – 1295
2014
Q4
$47K Buy
+245
New +$52.4K ﹤0.01% 1106

Other funds holding AXDX

BlackRock Japan's AXDX Position: Q3 2016 in Review

BlackRock Japan sold out of Accelerate Diagnostics (AXDX) in Q3 2016, closing a stake of 43 shares — an estimated $6K sold.

BlackRock Japan first reported a position in AXDX in Q4 2014 and held it in 5 quarters. The position peaked at $52K in Q4 2015. 103 funds tracked by Wall St. Rank hold AXDX as of Q3 2016.

  • BlackRock Japan reported no remaining Accelerate Diagnostics position as of Q3 2016 after selling out during the quarter.
  • BlackRock Japan sold 43 Accelerate Diagnostics shares in Q3 2016, an estimated $6K.
  • BlackRock Japan first reported a position in Accelerate Diagnostics in Q4 2014 and held it in 5 quarters.
  • BlackRock Japan's Accelerate Diagnostics position peaked at $52K in Q4 2015.
  • 103 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.